BioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform

Rymedi is proud to announce its newest collaboration with BioSpy, the creators of Prostate IQ®, a next generation prostate cancer screening test. This new partnership will ensure the highest efficiency and security of…

Continue ReadingBioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform

Rymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform

Rymedi has completed a Series A totaling $9 million with plans to expand the reach of our platform. The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s…

Continue ReadingRymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform

Rymedi Partners with Zeeve to Provide Substantial Cost Savings and Rapid Migration to Avalanche Subnets

In a strategic alignment that champions the fusion of technology and healthcare, Zeeve-the prominent blockchain infrastructure-as-a-service platform played a pivotal role in supporting RYMEDI, a rising healthcare tech star from…

Continue ReadingRymedi Partners with Zeeve to Provide Substantial Cost Savings and Rapid Migration to Avalanche Subnets

Rymedi Joins Carbon and Med Aditus CEOs Presenting on Data Management Innovation Enabling Distributed Manufacture of Quality Devices, Medicines and Vaccines

The following article was originally published by Triangle Global Health: The 2020 Triangle Global Health Annual Conference will explore global health in the COVID-19 era. Global health organizations in North…

Continue ReadingRymedi Joins Carbon and Med Aditus CEOs Presenting on Data Management Innovation Enabling Distributed Manufacture of Quality Devices, Medicines and Vaccines